title: Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
authors.affiliation: Liver Transplantation Center, Ospedali Riuniti de Bergamo, Largo Barozzi 1, 24128 Bergamo, Italy.
authors.forename: W
authors.initials: W
authors.lastname: Petz
authors.forename: M
authors.initials: M
authors.lastname: Spada
authors.forename: A
authors.initials: A
authors.lastname: Bertani
authors.forename: A
authors.initials: A
authors.lastname: Lucianctti
authors.forename: F
authors.initials: F
authors.lastname: Casagrande
authors.forename: M
authors.initials: M
authors.lastname: Guizzetti
authors.forename: V
authors.initials: V
authors.lastname: Corno
authors.forename: M
authors.initials: M
authors.lastname: Colledan
authors.forename: M
authors.initials: M
authors.lastname: Strazzabosco
authors.forename: B
authors.initials: B
authors.lastname: Gridelli
mesh_terms: D000328:Adult; D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab; D016559:Tacrolimus